Cargando…
Everolimus in acute kidney injury in a patient with breast cancer: a case report
INTRODUCTION: Everolimus, a mammalian target of Rapamycin inhibitor, has recently been approved for the treatment of metastatic estrogen receptor-positive breast cancer, in combination with exemestane at a daily dose of 10mg. In the literature, few cases of acute kidney injury have been reported rel...
Autores principales: | Donders, Francesca, Kuypers, Dirk, Wolter, Pascal, Neven, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364691/ https://www.ncbi.nlm.nih.gov/pubmed/25420955 http://dx.doi.org/10.1186/1752-1947-8-386 |
Ejemplares similares
-
Everolimus-associated Acute Kidney Injury in Patients with Metastatic Breast Cancer
por: Chandra, A., et al.
Publicado: (2017) -
Acute pancreatitis associated with everolimus after kidney transplantation: a case report
por: Fontana, Francesco, et al.
Publicado: (2016) -
Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function
por: Ha, Sung Hae, et al.
Publicado: (2014) -
Transfer of Everolimus into Colostrum of a Kidney Transplant Mother
por: Kociszewska-Najman, Bożena, et al.
Publicado: (2017) -
Severe everolimus-induced steatohepatis: a case report
por: Schieren, Gisela, et al.
Publicado: (2013)